Avantor, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Avantor, Inc. (AVTR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $6.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-11
- Avantor, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $6.10M, a 1.61% decline from fiscal 2024.
- Avantor, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $6.20M, a 264.71% increase from fiscal 2023.
- Avantor, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $1.70M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $6.10M 10-K · filed 2026-02-11 |
| 2024-12-31 | $6.20M 10-K · filed 2026-02-11 |
| 2023-12-31 | $1.70M 10-K · filed 2026-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |